Eli Lilly & Co. Share Price
NYSE: LLY | Mega CapEli Lilly & Co. Stock Performance
Eli Lilly & Co. Share Price Today
As of 31 October 2026, Eli Lilly & Co.'s share price is $1,415.05. The stock opened at $1,428.23, compared to its previous close of $1,371.32. During today's trading session, Eli Lilly & Co.'s share price traded between $1,409.20 and $1,447.00, with an average price of $1,428.10. Over the past 52 weeks, the stock has recorded a high of $1,447.00 and a low of $812.87. In terms of performance, Eli Lilly & Co.'s share price has risen by 51.36% over the last six months and is up 63.98% on a year-on-year basis.
Eli Lilly & Co. Share Price Chart
Eli Lilly & Co. Quarterly Profit & Loss
All figures in USD
Eli Lilly & Co. Annual Profit & Loss
All figures in USD
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Eli Lilly & Co. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1,149.24 | $1,417.06 | +21.93% |
Sep 2026 | $1,184.81 | $1,162.17 | -1.15% |
Aug 2026 | $1,151.54 | $1,175.64 | +2.33% |
Jul 2026 | $1,211.52 | $1,148.86 | -4.21% |
Jun 2026 | $1,096.77 | $1,199.36 | +8.54% |
May 2026 | $947.49 | $1,105.00 | +18.20% |
Apr 2026 | $930.00 | $934.86 | +1.65% |
Mar 2026 | $1,046.80 | $919.73 | -12.62% |
Feb 2026 | $1,039.78 | $1,052.58 | +1.43% |
Jan 2026 | $1,071.36 | $1,037.76 | -3.47% |
Dec 2025 | $1,073.69 | $1,075.11 | +0.01% |
Nov 2025 | $865.59 | $1,075.06 | +24.58% |